Literature DB >> 26721966

The INPULSIS trials of idiopathic pulmonary fibrosis treatment: explaining further discrepancies on exacerbations.

Samy Suissa1, Pierre Ernst2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26721966     DOI： 10.1183/13993003.01274-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  2 in total

Review 1.  Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review.

Authors:  Caterina Vacchi; Marco Sebastiani; Giulia Cassone; Stefania Cerri; Giovanni Della Casa; Carlo Salvarani; Andreina Manfredi
Journal:  J Clin Med       Date:  2020-02-03       Impact factor: 4.241

Review 2.  Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung disease.

Authors:  Erin M Wilfong; Rohit Aggarwal
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-12-09       Impact factor: 3.625
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.